John D Clemens Selected Research

Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)

1/2022	Prevention of Typhoid Fever by Existing Improvements in Household Water, Sanitation, and Hygiene, and the Use of the Vi Polysaccharide Typhoid Vaccine in Poor Urban Slums: Results from a Cluster-Randomized Trial.
12/2021	Assessment of Vaccine Herd Protection: Lessons Learned From Cholera and Typhoid Vaccine Trials.
3/2021	Case Report: Typhoid Fever Complicated by Ileal Perforation in an Urban Slum of Dhaka, Bangladesh.
1/2020	Protection conferred by typhoid fever against recurrent typhoid fever in urban Kolkata.
1/2020	Use of Typhoid Vi-Polysaccharide Vaccine as a Vaccine Probe to Delineate Clinical Criteria for Typhoid Fever.
5/2014	Immune responses to Vi capsular polysaccharide typhoid vaccine in children 2 to 16 years old in Karachi, Pakistan, and Kolkata, India.
5/2010	Population impact of Vi capsular polysaccharide vaccine.
7/2008	Typhoid vaccination: the Asian experience.
12/2007	Implementation of good clinical practice guidelines in vaccine trials in developing countries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John D Clemens Research Topics

Disease

49	Cholera 10/2022 - 04/2003
44	Typhoid Fever (Typhoid) 11/2022 - 12/2002
8	Diarrhea 11/2021 - 04/2002
7	Fever (Fevers) 01/2022 - 12/2003
5	Japanese Encephalitis 11/2022 - 01/2003
5	Infections 08/2021 - 02/2010
5	Bacillary Dysentery (Shigellosis) 07/2006 - 09/2004
3	COVID-19 01/2022 - 02/2021
3	Hepatitis A (Hepatitis, Infectious) 01/2022 - 05/2006
3	Dehydration (Water Stress) 11/2021 - 05/2016
2	Dengue (Dengue Fever) 07/2020 - 12/2003
2	Communicable Diseases (Infectious Diseases) 01/2019 - 01/2016
1	Myalgia 01/2022
1	Anosmia 01/2022
1	Hypertensive Crisis 01/2022
1	Cough 01/2022
1	Fatigue 01/2022
1	Neuralgia (Stump Neuralgia) 01/2022
1	Syncope (Fainting) 01/2022
1	Supraventricular Tachycardia 01/2022
1	Unconsciousness (Loss of Consciousness) 01/2022
1	Vision Disorders (Hemeralopia) 01/2022
1	Guillain-Barre Syndrome 01/2022
1	Dyskinesias (Dyskinesia) 01/2022
1	Intestinal Perforation 03/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Vipoma (WDHA) 07/2020
1	Salmonella Infections (Salmonellosis) 01/2020
1	Hepatitis E 01/2020
1	Parasitic Diseases (Parasitic Disease) 03/2016
1	Malaria 03/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2015
1	Bacterial Infections (Bacterial Infection) 03/2009
1	Pneumococcal Infections 03/2009
1	Paratyphoid Fever 12/2006
1	Pain (Aches) 05/2006
1	HIV Infections (HIV Infection) 02/2005
1	Rabies (Hydrophobia) 04/2003
1	Sudden Infant Death (SID) 01/2003
1	Asphyxia (Suffocation) 01/2003
1	Schistosomiasis (Bilharziasis) 12/2002
1	Vomiting 04/2002
1	Birth Weight (Birth Weights) 01/2002

Drug/Important Bio-Agent (IBA)

65	VaccinesIBA 11/2022 - 04/2002
24	Cholera Vaccines FDA Link 10/2022 - 01/2004
17	Polysaccharides (Glycans)IBA 01/2022 - 09/2004
10	Conjugate VaccinesIBA 11/2022 - 11/2018
9	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2022 - 12/2007
5	tartrate-sensitive acid phosphataseIBA 10/2019 - 11/2015
4	TCVSIBA 11/2022 - 01/2019
4	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 07/2006
3	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 11/2022 - 01/2021
3	shancholIBA 01/2022 - 05/2016
2	Dengue VaccinesIBA 07/2020 - 12/2003
2	Pharmaceutical PreparationsIBA 11/2018 - 03/2011
2	Drinking WaterIBA 01/2017 - 01/2011
2	Immunoglobulin G (IgG)IBA 05/2014 - 12/2002
2	Hepatitis A Vaccines (Hepatitis A Vaccine)IBA 08/2012 - 07/2009
2	LipopolysaccharidesIBA 05/2011 - 12/2006
2	Indicators and Reagents (Reagents)IBA 06/2010 - 01/2004
2	AntibodiesIBA 02/2005 - 12/2002
1	COVID-19 VaccinesIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 11/2021
1	Solid WasteIBA 11/2021
1	A 19IBA 03/2021
1	Ivermectin (Mectizan)FDA Link 02/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 07/2020
1	typhoid Vi polysaccharide vaccine (Typhim Vi)FDA Link 01/2020
1	hecolinIBA 01/2020
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Detergents (Detergent)IBA 01/2016
1	Chlorophyll AIBA 09/2015
1	Bronchodilator Agents (Bronchodilators)IBA 01/2015
1	GoldIBA 01/2015
1	Bacterial VaccinesIBA 01/2012
1	Immunoglobulin M (IgM)IBA 05/2011
1	Combined VaccinesIBA 09/2010
1	Antimalarials (Antimalarial Agents)IBA 02/2010
1	ElementsIBA 05/2009
1	Cholera ToxinIBA 05/2009
1	4-hexyloxyaniline (HOA)IBA 03/2009
1	AntigensIBA 03/2009
1	FluoroquinolonesIBA 04/2008
1	tartaric acid (tartrate)FDA Link 12/2006
1	Peru 15IBA 08/2005
1	Vitamin A (Retinol)FDA LinkGeneric 01/2004
1	ZincIBA 01/2004
1	SmokeIBA 01/2003
1	Soaps (Soap)IBA 12/2002
1	Antimony Potassium TartrateIBA 12/2002
1	Caffeine (No Doz)FDA LinkGeneric 01/2002

Therapy/Procedure

4	Fluid Therapy (Oral Rehydration Therapy) 11/2021 - 11/2007
4	Injections 05/2010 - 12/2002
2	Therapeutics 09/2017 - 11/2007
1	Self Administration (Administration, Self) 01/2019